May 19, 2022
The Third Circuit on Thursday ruled that wholesale pharmaceutical distributors Oak Drugs Inc. and PriMed Pharmaceuticals LLC cannot sue a private entity for alleged federal due process violations stemming from delaying their industry accreditation, reasoning that constitutional claims are only applicable when a state actor is involved.
January 06, 2022
Constitutional law will dominate Third Circuit arguments this month in cases brought by pharmaceutical companies claiming injuries over delayed industry accreditation and landlords battling New Jersey's pandemic relief for renters, while arbitration matters muddle both a union's fight with Merck and a water pump contract dispute.